Actively Recruiting

Age: 18Years - 85Years
All Genders
NCT05483452

Accuracy of Coplanar Template Assisted Seed Implantation for Abdominal and Pelvic Cancer

Led by Peking University Third Hospital · Updated on 2024-06-18

34

Participants Needed

1

Research Sites

56 weeks

Total Duration

On this page

AI-Summary

What this Trial Is About

In recent years, template guidance has been applied and developed in the field of puncture related operations, such as template-assisted radioactive seed implantation. With the guidance of template, needle pathway of seed implantation, biopsy and fiducial marker implantation can be precisely planned actual operation, which is conducive to the accurate proceeding. Templates can be divided into coplanar templates and non-coplanar templates. The digital coplanar template coordinate puncture system has been developed in China and has been applied in clinical practice. In previous studies, coplanar template assisted CT-guided radioactive seed implantation has good clinical feasibility for head and neck cancer. However, the accuracy of Coplanar Template Assisted Seed Implantation for Abdominal and Pelvic cancer are lacking in prospective studies. The study aims to prospectively observe the accuracy and safety of Coplanar Template Assisted Seed Implantation for Abdominal and Pelvic cancer.

CONDITIONS

Official Title

Accuracy of Coplanar Template Assisted Seed Implantation for Abdominal and Pelvic Cancer

Who Can Participate

Age: 18Years - 85Years
All Genders

Eligibility Criteria

Eligible

You may qualify if you...

  • Ages 18 to 85
  • Single or multiple abdominal or pelvic tumors (solid, partially solid)
  • Not currently taking drugs that affect coagulation or platelet aggregation, or such drugs have been stopped for a sufficient period (e.g., 1 week)
  • Karnofsky Performance Status (KPS) greater than 60 with expected survival over 3 months, no serious or uncontrolled underlying diseases, and able to tolerate puncture
  • Planned seed implantation with an applicable puncture path
  • Provided informed consent
Not Eligible

You will not qualify if you...

  • Poor organ function such as liver decompensation
  • Tumors close to blood vessels or intestines, or presence of portal vein hypertension or superior vena cava compression increasing risk of bleeding or intestinal injury
  • Poor compliance or inability to complete required study coordination
  • Considered inappropriate or unwilling to participate for other reasons

AI-Screening

AI-Powered Screening

Complete this quick 3-step screening to check your eligibility

1
2
3
+1

Trial Site Locations

Total: 1 location

1

Peking University Third Hospital

Beijing, Beijing Municipality, China

Actively Recruiting

Loading map...

Research Team

B

Bin Qiu, M.D.

CONTACT

How is the study designed?

Study Type

OBSERVATIONAL

Masking

N/A

Allocation

N/A

Model

N/A

Primary Purpose

N/A

Number of Arms

0

Not the Right Trial for You?

Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.

Already have an account? Log in here